Company Filing History:
Years Active: 2000-2013
Title: Angelika Grossman: Innovator in Medical Biotechnology
Introduction
Angelika Grossman is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of medical biotechnology, particularly in the development of innovative therapies and treatments. With a total of 3 patents to her name, Grossman is recognized for her groundbreaking work in the medical community.
Latest Patents
Grossman's latest patents include an antibody to human Zcyto-10 polypeptide. This invention describes antibodies that specifically bind to a mammalian cytokine-like polypeptide known as Zcyto10. These antibodies, which include monoclonal antibodies and antigen-binding fragments, are useful for promoting wound healing and stimulating platelet proliferation. Another notable patent is a method for inhibiting the formation of seromas using factor XIII. This method involves administering factor XIII, either locally at the site of a wound or surgery or systemically, to inhibit seroma formation.
Career Highlights
Angelika Grossman is currently associated with Zymogenetics, Inc., where she continues to advance her research and innovations. Her work has had a profound impact on the development of therapeutic solutions in the medical field.
Collaborations
Throughout her career, Grossman has collaborated with esteemed colleagues, including Willem E. Fibbe and Darrell C. Conklin. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Angelika Grossman is a trailblazer in the field of medical biotechnology, with a focus on innovative treatments that enhance healing and recovery. Her contributions through her patents and collaborations continue to shape the future of medical science.